Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors
Clinical trial NCT06131216 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06131216
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-12-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.